JP2022544246A5 - - Google Patents

Info

Publication number
JP2022544246A5
JP2022544246A5 JP2022508564A JP2022508564A JP2022544246A5 JP 2022544246 A5 JP2022544246 A5 JP 2022544246A5 JP 2022508564 A JP2022508564 A JP 2022508564A JP 2022508564 A JP2022508564 A JP 2022508564A JP 2022544246 A5 JP2022544246 A5 JP 2022544246A5
Authority
JP
Japan
Application number
JP2022508564A
Other languages
Japanese (ja)
Other versions
JPWO2021028686A5 (https=
JP2022544246A (ja
Filing date
Publication date
Priority claimed from PCT/GB2020/051831 external-priority patent/WO2021019246A1/en
Application filed filed Critical
Priority claimed from PCT/GB2020/051923 external-priority patent/WO2021028686A1/en
Publication of JP2022544246A publication Critical patent/JP2022544246A/ja
Publication of JPWO2021028686A5 publication Critical patent/JPWO2021028686A5/ja
Publication of JP2022544246A5 publication Critical patent/JP2022544246A5/ja
Pending legal-status Critical Current

Links

JP2022508564A 2019-08-13 2020-08-13 修飾された多量体二環式ペプチドリガンド Pending JP2022544246A (ja)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US201962885947P 2019-08-13 2019-08-13
US62/885,947 2019-08-13
GBPCT/GB2020/051831 2020-07-30
PCT/GB2020/051831 WO2021019246A1 (en) 2019-07-30 2020-07-30 Heterotandem bicyclic peptide complexes
PCT/GB2020/051923 WO2021028686A1 (en) 2019-08-13 2020-08-13 Modified multimeric bicyclic peptide ligands

Publications (3)

Publication Number Publication Date
JP2022544246A JP2022544246A (ja) 2022-10-17
JPWO2021028686A5 JPWO2021028686A5 (https=) 2023-08-25
JP2022544246A5 true JP2022544246A5 (https=) 2023-08-25

Family

ID=74570355

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2022508564A Pending JP2022544246A (ja) 2019-08-13 2020-08-13 修飾された多量体二環式ペプチドリガンド

Country Status (5)

Country Link
US (1) US20220275053A1 (https=)
EP (1) EP4013501A1 (https=)
JP (1) JP2022544246A (https=)
CN (1) CN114787197A (https=)
WO (1) WO2021028686A1 (https=)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP6882978B2 (ja) 2014-10-29 2021-06-02 バイスクルアールディー・リミテッド Mt1−mmpに特異的な二環性ペプチドリガンド
JP7301757B2 (ja) 2017-06-26 2023-07-03 バイスクルアールディー・リミテッド 検出可能部分を持つ二環式ペプチドリガンドおよびその使用
CN111183147B (zh) 2017-08-04 2024-07-05 拜斯科技术开发有限公司 Cd137特异性的双环肽配体
TWI825046B (zh) 2017-12-19 2023-12-11 英商拜西可泰克斯有限公司 Epha2特用之雙環胜肽配位基
JP2021514953A (ja) 2018-02-23 2021-06-17 バイスクルテクス・リミテッド 多量体二環式ペプチドリガンド
IL279489B2 (en) 2018-06-22 2025-10-01 Bicycletx Ltd Bicyclic peptide ligands specific for nectin-4, a drug conjugate containing the peptide ligands and a pharmaceutical composition containing the drug conjugate
GB201820295D0 (en) 2018-12-13 2019-01-30 Bicyclerd Ltd Bicyclic peptide ligands specific for MT1-MMP
GB201820288D0 (en) 2018-12-13 2019-01-30 Bicycle Tx Ltd Bicycle peptide ligaands specific for MT1-MMP
GB201820325D0 (en) 2018-12-13 2019-01-30 Bicyclerd Ltd Bicyclic peptide ligands specific for psma
US12551567B2 (en) 2018-12-21 2026-02-17 Bicyclerd Limited Bicyclic peptide ligands specific for PD-L1
JP2022514618A (ja) 2018-12-21 2022-02-14 バイスクルテクス・リミテッド Pd-l1に特異的な二環式ペプチドリガンド
GB201900529D0 (en) 2019-01-15 2019-03-06 Bicycletx Ltd Bicyclic peptide ligands specific for CD38
TWI860386B (zh) 2019-07-30 2024-11-01 英商拜西可泰克斯有限公司 異質雙環肽複合物
ES3033517T3 (en) * 2019-10-03 2025-08-05 Bicycletx Ltd Heterotandem bicyclic peptide complexes
IL300248A (en) 2020-08-03 2023-03-01 Bicycletx Ltd peptide-based linkers
GB202016331D0 (en) * 2020-10-15 2020-12-02 Bicyclerd Ltd Bicyclic peptide ligand drug conjugates
US20250186539A2 (en) * 2021-01-11 2025-06-12 Bicycletx Limited Methods for treating cancer
EP4308586A1 (en) * 2021-03-19 2024-01-24 BicycleTX Limited Bicyclic peptide ligands specific for trem2
MX2024003876A (es) 2021-09-29 2024-04-19 Conjustar Zhuhai Biologics Co Ltd Conjugado farmaco-polipeptido triciclico y sus aplicaciones.
CN114133434B (zh) * 2021-12-01 2022-11-15 北京大学第一医院 靶向Nectin-4的双环肽核素配体与探针

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1452868A2 (en) 2003-02-27 2004-09-01 Pepscan Systems B.V. Method for selecting a candidate drug compound
DK1844337T3 (da) 2005-01-24 2013-09-30 Pepscan Systems Bv Bindingsforbindelser, immunogene forbindelser og peptidmimetika
JP4030067B2 (ja) * 2005-03-22 2008-01-09 ロート製薬株式会社 新規ペプチド
AU2009211253B2 (en) 2008-02-05 2014-11-06 Bicyclerd Limited Methods and compositions
EP3181146A1 (en) * 2015-12-16 2017-06-21 Ruprecht-Karls-Universität Heidelberg Cyclic ntcp-targeting peptides and their uses as entry inhibitors
TWI825046B (zh) * 2017-12-19 2023-12-11 英商拜西可泰克斯有限公司 Epha2特用之雙環胜肽配位基
JP2021514953A (ja) * 2018-02-23 2021-06-17 バイスクルテクス・リミテッド 多量体二環式ペプチドリガンド
JP7551500B2 (ja) * 2018-04-04 2024-09-17 バイスクルテクス・リミテッド ヘテロタンデム二環式ペプチド複合体

Similar Documents

Publication Publication Date Title
BR112023005462A2 (https=)
JP2022544246A5 (https=)
BR112023012656A2 (https=)
CL2025004052A1 (es) Derivados pirazolo[3,2-c]piridinona, inhibidores egfr y/o her2; composición; uso en cáncer
BR112021014123A2 (https=)
BR112023009656A2 (https=)
BR112022009896A2 (https=)
BR112021017747A2 (https=)
BR112022024743A2 (https=)
BR112022026905A2 (https=)
BR112023011738A2 (https=)
BR112023004146A2 (https=)
BR112023006729A2 (https=)
BR102021018859A2 (https=)
BR102021015500A2 (https=)
BR112023016292A2 (https=)
BR112023011610A2 (https=)
BR112023011539A2 (https=)
BR112023008976A2 (https=)
BR102021020147A2 (https=)
BR102021018926A2 (https=)
BR102021018167A2 (https=)
BR102021017576A2 (https=)
BR102021016837A2 (https=)
BR102021016551A2 (https=)